DK1456238T3 - Produktion af F(ab')2-fragmenter i pattedyrceller - Google Patents
Produktion af F(ab')2-fragmenter i pattedyrcellerInfo
- Publication number
- DK1456238T3 DK1456238T3 DK02789019T DK02789019T DK1456238T3 DK 1456238 T3 DK1456238 T3 DK 1456238T3 DK 02789019 T DK02789019 T DK 02789019T DK 02789019 T DK02789019 T DK 02789019T DK 1456238 T3 DK1456238 T3 DK 1456238T3
- Authority
- DK
- Denmark
- Prior art keywords
- fragments
- production
- mammalian cells
- antibody fragments
- bivalent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/624—Disulfide-stabilized antibody (dsFv)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL0100917 | 2001-12-17 | ||
| PCT/NL2002/000841 WO2003051927A2 (en) | 2001-12-17 | 2002-12-17 | Production of f(ab')2 fragments in mammalian cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1456238T3 true DK1456238T3 (da) | 2008-08-18 |
Family
ID=19760784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02789019T DK1456238T3 (da) | 2001-12-17 | 2002-12-17 | Produktion af F(ab')2-fragmenter i pattedyrceller |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20050048038A1 (da) |
| EP (1) | EP1456238B1 (da) |
| AT (1) | ATE397019T1 (da) |
| AU (1) | AU2002353662B2 (da) |
| CA (1) | CA2470579C (da) |
| DE (1) | DE60226896D1 (da) |
| DK (1) | DK1456238T3 (da) |
| ES (1) | ES2307807T3 (da) |
| NZ (1) | NZ533332A (da) |
| SI (1) | SI1456238T1 (da) |
| WO (1) | WO2003051927A2 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6855544B1 (en) | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
| US7297680B2 (en) | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
| US7604960B2 (en) | 1999-04-15 | 2009-10-20 | Crucell Holland B.V. | Transient protein expression methods |
| US8236561B2 (en) | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
| US7527961B2 (en) | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
| US7192759B1 (en) | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
| US7521220B2 (en) | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| JP4480398B2 (ja) | 2001-12-07 | 2010-06-16 | クルセル ホランド ベー ヴェー | ウイルス、ウイルス分離株及びワクチンの製造方法 |
| AU2002353662B2 (en) | 2001-12-17 | 2009-04-23 | Crucell Holland B.V. | Production of F(ab')2 fragments in mammalian cells |
| KR101183770B1 (ko) | 2003-05-09 | 2012-09-17 | 크루셀 홀란드 비.브이. | E1-불멸화된 세포의 배양물 및 이로부터 생성 수율을 증가시키기 위한 동일물의 배양 방법 |
| EP3680252A4 (en) | 2017-10-02 | 2021-04-28 | Laboratorios Silanes, S.A. de C.V. | HIGH PERFORMANCE PROCESS FOR PREPARATION OF POISON ANTIDOTS WITH F (AB ') - 2 ANTIBODY FRAGMENTS |
| WO2023205656A2 (en) * | 2022-04-18 | 2023-10-26 | John Paul Ii Medical Research Institute | Immortalized cells for production of bioproducts, methods of producing bioproducts with an immortalized cell, and methods of making immortalized cells for production of bioproducts |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4624846A (en) * | 1983-07-29 | 1986-11-25 | Immunomedics, Inc. | Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles |
| DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
| US5168062A (en) * | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| DE3920358A1 (de) * | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| CA2116774C (en) * | 1991-09-19 | 2003-11-11 | Paul J. Carter | Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies |
| KR100470180B1 (ko) | 1995-06-15 | 2005-02-04 | 크루셀 홀란드 비.브이. | 유전자 요법에 사용할 수 있는 인간의 재조합아데노바이러스 패키징 시스템 |
| CN100457914C (zh) * | 1999-04-15 | 2009-02-04 | 荷兰克鲁塞尔公司 | 用编码腺病毒e1蛋白的序列在人体细胞中生产重组蛋白 |
| EP1103610A1 (en) | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
| EP1130099A1 (en) * | 2000-02-25 | 2001-09-05 | Crucell Holland B.V. | Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| AU2002353662B2 (en) | 2001-12-17 | 2009-04-23 | Crucell Holland B.V. | Production of F(ab')2 fragments in mammalian cells |
-
2002
- 2002-12-17 AU AU2002353662A patent/AU2002353662B2/en not_active Ceased
- 2002-12-17 US US10/499,298 patent/US20050048038A1/en not_active Abandoned
- 2002-12-17 NZ NZ533332A patent/NZ533332A/en not_active IP Right Cessation
- 2002-12-17 WO PCT/NL2002/000841 patent/WO2003051927A2/en not_active Ceased
- 2002-12-17 DE DE60226896T patent/DE60226896D1/de not_active Expired - Lifetime
- 2002-12-17 CA CA2470579A patent/CA2470579C/en not_active Expired - Lifetime
- 2002-12-17 AT AT02789019T patent/ATE397019T1/de active
- 2002-12-17 EP EP02789019A patent/EP1456238B1/en not_active Expired - Lifetime
- 2002-12-17 SI SI200230701T patent/SI1456238T1/sl unknown
- 2002-12-17 DK DK02789019T patent/DK1456238T3/da active
- 2002-12-17 ES ES02789019T patent/ES2307807T3/es not_active Expired - Lifetime
-
2008
- 2008-02-14 US US12/070,145 patent/US7537916B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2470579C (en) | 2012-03-06 |
| SI1456238T1 (sl) | 2008-08-31 |
| WO2003051927A3 (en) | 2003-11-20 |
| DE60226896D1 (de) | 2008-07-10 |
| ATE397019T1 (de) | 2008-06-15 |
| US7537916B2 (en) | 2009-05-26 |
| ES2307807T3 (es) | 2008-12-01 |
| WO2003051927A2 (en) | 2003-06-26 |
| CA2470579A1 (en) | 2003-06-26 |
| US20050048038A1 (en) | 2005-03-03 |
| EP1456238A2 (en) | 2004-09-15 |
| AU2002353662B2 (en) | 2009-04-23 |
| NZ533332A (en) | 2005-07-29 |
| US20080166767A1 (en) | 2008-07-10 |
| EP1456238B1 (en) | 2008-05-28 |
| AU2002353662A1 (en) | 2003-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1362093A4 (en) | QUICK PRODUCTION OF MONOCLONAL ANTIBODIES | |
| DK1379671T3 (da) | Fremgangsmåder til dyrkning af circovirus | |
| IL162648A0 (en) | Cellular compositions and methods of making and using them | |
| AU2002364935A1 (en) | Enhancement of immune responses by 4-1bb-binding agents | |
| FR15C0055I1 (da) | ||
| TR200003513T2 (tr) | Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları | |
| DE60037450D1 (de) | Funf-helix protein | |
| HUP0105052A2 (hu) | Eljárások nukleinsav amplifikálására és szekvenálására | |
| CY1105772T1 (el) | Συνθεσεις και μεθοδοι για βελτιωμενη κυτταρικη καλλιεργεια | |
| BR0015224A (pt) | Anticorpo anti-antìgeno de célula estaminal prostática (psca) isolado, anticorpo monoclonal anti-psca, ácido nucleico isolado, vetor de expressão, célula, célula hospedeira, método de produção de anticorpo, composição método in vitro para matar uma célula cancerosa que expresse psca, uso de uma anticorpo monoclonal anti-psca e artigo industrializado | |
| TR200602095T2 (tr) | Hümanize Anti-LT-Beta-R antikorları | |
| DK0922102T3 (da) | Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf | |
| SI1456238T1 (sl) | Proizvodnja f(ab)2 fragmentov v sesalskih celicah | |
| DK1492869T3 (da) | Transplantataccept-inducerende celler af monocytisk oprindelse, deres fremstilling og anvendelse | |
| DE60332966D1 (de) | Kollektoren in zwei hemispheren | |
| NZ592159A (en) | Means and methods for influencing the stability of antibody producing cells | |
| WO2002010337A3 (en) | Method of cloning porcine animals | |
| EP0763057A4 (en) | METHOD OF MULTIPLICATION AND DIFFERENTIATION OF B CELLS AND THEIR USE | |
| DK1321477T3 (da) | Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner | |
| PT1200561E (pt) | Clone celular recombinante estavel, sua producao e utilizacao | |
| BR0100982A (pt) | Processo para a preparação de derivados deresorcinol | |
| CY1111775T1 (el) | Πνευμονικα κυτταρα βαμβακοαρουραιου για καλλιεργεια ιου | |
| NO20061470L (no) | Fremgangsmate for fremstilling av gamma-karboksylerte proteiner | |
| EP1381673A4 (en) | COMPOSITIONS AND METHODS SUITABLE FOR HIV INFECTION | |
| PL367306A1 (pl) | Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania |